R
Raffaele Landolfi
Researcher at Catholic University of the Sacred Heart
Publications - 264
Citations - 10070
Raffaele Landolfi is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Engineering & Polycythemia vera. The author has an hindex of 41, co-authored 234 publications receiving 8848 citations. Previous affiliations of Raffaele Landolfi include The Catholic University of America & Agostino Gemelli University Polyclinic.
Papers
More filters
Journal ArticleDOI
Low-Dose Aspirin for the Prevention of Atherothrombosis
TL;DR: This review considers the role of low-dose aspirin for the prevention of atherothrombosis as well as clinical and epidemiologic studies of aspirin as an antiplatelet agent, with special emphasis on the benefits and risks in different patient populations.
Journal ArticleDOI
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera
Raffaele Landolfi,Roberto Marchioli,Jack Kutti,Heinz Gisslinger,Gianni Tognoni,Carlo Patrono,Tiziano Barbui +6 more
TL;DR: Low-dose aspirin can safely prevent thrombotic complications in patients with polycythemia vera who have no contraindications to such treatment, and reduced the risk of the combined end point of nonf fatal myocardial infarction, nonfatal stroke, pulmonary embolism, major venous thromBosis, or death from cardiovascular causes.
Journal ArticleDOI
Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera
Roberto Marchioli,Guido Finazzi,Raffaele Landolfi,Jack Kutti,Heinz Gisslinger,Carlo Patrono,Raphael Marilus,Ana Villegas,Gianni Tognoni,Tiziano Barbui +9 more
TL;DR: The persistently high mortality rate from hematologic malignancies characterizes the unmet therapeutic need of polycythemic patients and suggests a priority for future studies in this disease.
Journal ArticleDOI
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori.
Antonio Gasbarrini,Francesco Franceschi,Raffaele Tartaglione,Raffaele Landolfi,Paolo Pola,Giovanni Gasbarrini +5 more
TL;DR: Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor and monoclonal antibodies against Helicobacter pylori cross-react with human tissue.
Journal ArticleDOI
Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development
Maria Assunta Zocco,Enrico Di Stasio,Raimondo De Cristofaro,Marialuisa Novi,Maria Elena Ainora,Francesca Romana Ponziani,Laura Riccardi,Stefano Lancellotti,Angelo Santoliquido,Roberto Flore,Maurizio Pompili,Gian Ludovico Rapaccini,Paolo Tondi,Giovanni Gasbarrini,Raffaele Landolfi,Antonio Gasbarrini +15 more
TL;DR: Lower concentrations of natural coagulation inhibitors are frequently detected in patients with liver cirrhosis and a reduced portal flow velocity seems to be the most important predictive variable for PVT development in patientsWith cirrhotic patients.